**Core Concept:** Nitric oxide (NO) is a gaseous molecule that plays a crucial role as a signaling molecule in various physiological processes, including vasodilation, neurotransmission, and immune response. It is synthesized from L-arginine by nitric oxide synthase (NOS) enzymes, which can be endothelial (eNOS), inducible (iNOS), and neuronal (nNOS).

**Why the Correct Answer is Right:**

Nitric oxide is a key molecule in the regulation of vascular tone, acting as a vasodilator. It causes smooth muscle relaxation in blood vessels by activating soluble guanylate cyclase (sGC) and elevating cyclic guanosine monophosphate (cGMP) levels, leading to the inhibition of myosin light chain kinase (MLCK) and subsequent relaxation of smooth muscle cells.

**Why Each Wrong Option is Incorrect:**

A. This statement is correct: Nitric oxide contributes to the regulation of vascular tone.
B. While NOS enzymes are involved in NO production, this statement is incorrect as NO does not cause vasoconstriction.
C. This statement is not correct as NO acts as a vasodilator, not a vasoconstrictor.
D. This statement is incorrect as NO does not directly cause smooth muscle contraction, but instead, it helps maintain vascular tone by acting as a modulator.

**Clinical Pearl / High-Yield Fact:**

Understanding the role of nitric oxide in vasodilation is essential for understanding cardiovascular pathophysiology and pharmacotherapy, particularly in disorders like hypertension, atherosclerosis, and erectile dysfunction. For example, in hypertension, NO production might be reduced, contributing to vasoconstriction and increased blood pressure. In erectile dysfunction, NO deficiency in the penile tissue may cause impaired endothelium-dependent relaxation, leading to insufficient penile tumescence during sexual stimulation.

**Correct Answer:** C. Nitric oxide (NO) directly causes smooth muscle relaxation.

NO acts as a vasodilator by binding to guanylate cyclase (GC) enzyme, converting it from an inactive form (GC-A) to an active form (GC-B), which elevates cyclic guanosine monophosphate (cGMP) levels. This leads to the inhibition of myosin light chain kinase (MLCK) and subsequent smooth muscle relaxation.